tetano
Editor, Senior Moderator
Clin Case Rep
. 2023 Mar 2;11(3):e7001.
doi: 10.1002/ccr3.7001. eCollection 2023 Mar.
Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer-BioNTech COVID-19 vaccination: A case report
Shungo Yano[SUP] 1 [/SUP], Taiju Miyagami[SUP] 1 [/SUP], Takayuki Furusaka[SUP] 1 [/SUP], Nagamasa Kano[SUP] 1 [/SUP], Toshio Naito[SUP] 1 [/SUP]
Affiliations
Abstract
Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA-based coronavirus disease 2019 (COVID-19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution.
Keywords: COVID‐19; adverse events following immunization; case report; deep vein thrombosis; hypereosinophilic syndrome.
. 2023 Mar 2;11(3):e7001.
doi: 10.1002/ccr3.7001. eCollection 2023 Mar.
Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer-BioNTech COVID-19 vaccination: A case report
Shungo Yano[SUP] 1 [/SUP], Taiju Miyagami[SUP] 1 [/SUP], Takayuki Furusaka[SUP] 1 [/SUP], Nagamasa Kano[SUP] 1 [/SUP], Toshio Naito[SUP] 1 [/SUP]
Affiliations
- PMID: 36873062
- PMCID: PMC9979965
- DOI: 10.1002/ccr3.7001
Abstract
Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA-based coronavirus disease 2019 (COVID-19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution.
Keywords: COVID‐19; adverse events following immunization; case report; deep vein thrombosis; hypereosinophilic syndrome.